Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Jun 17, 2013 aberman michael s Officer Option Execute 3,900 24.00
Jun 13, 2013 roberts william Officer Acquisition (Non Open Market) 4,000 n/a
Jun 13, 2013 roberts william Officer Disposition (Non Open Market) 4,000 n/a
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
May 28, 2013 goldstein joseph l Director Sell 4,000 252.20
May 23, 2013 ryan arthur f Director Disposition (Non Open Market) 3,000 n/a
May 21, 2013 goldberg murray a Officer Disposition (Non Open Market) 4,061 n/a
May 21, 2013 goldberg murray a Officer Option Execute 4,023 16.80 - 20.32
May 21, 2013 goldberg murray a Officer Automatic Sell 66,835 255.52 - 264.61
May 20, 2013 goldberg murray a Officer Automatic Sell 81,132 266.64
May 20, 2013 goldberg murray a Officer Option Execute 147,967 16.80 - 53.18
May 20, 2013 goldstein joseph l Director Acquisition (Non Open Market) 4,000 n/a
May 17, 2013 brown michael s Director Sell 5,000 269.00 - 270.20
May 15, 2013 brown michael s Director Sell 10,000 278.28
May 15, 2013 brown michael s Director Option Execute 15,000 24.41
May 14, 2013 aberman michael s Officer Automatic Sell 5,529 278.72 - 281.72
May 13, 2013 aberman michael s Officer Automatic Sell 6,971 275.97
May 13, 2013 aberman michael s Officer Option Execute 12,500 24.00
Showing 181-200 of 821 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)